Prohibition on requiring prior authorization of payment for substance use disorder treatment; rules. (1) As used in this section, “medication-assisted treatment” means any medication, and the dispensing or administering of the medication, that is approved by the United States Food and Drug Administration on or before January 1, 2024, for the treatment of substance use disorders, and that is used for that purpose, including opioid and opiate addiction

(2) The Oregon Health Authority shall prohibit coordinated care organizations and public payers of health insurance from requiring prior authorization for the reimbursement of the costs of medication-assisted treatment.

(3) Notwithstanding subsection (2) of this section, a coordinated care organization may require prior authorization of a brand name drug for medication-assisted treatment if a generic equivalent is available to substitute for a prescribed brand name drug. As used in this subsection, a different formulation of the medication is not a generic equivalent.

(4) The authority may adopt rules to carry out this section. [2019 c.583 §7; 2024 c.70 §5]

BONE MARROW DONOR PROGRAM